Pap smear reimbursement
This article was originally published in The Gray Sheet
House bill to increase the Medicare rate for pap smear lab work from $7.15 to $14.60 - the national average production cost of the tests - is introduced June 18 by Rep. Neil Abercrombie ( D-Hawaii). The Investment in Women's Health Act of 1998 would take effect in January 1999. "We can't afford to let economic pressures prevent medical labs from continuing pap smear work," Abercrombie states in a same day release
You may also be interested in...
An upturn in M&A activity across the whole healthcare sector is expected in 2021, with the COVID-19 pandemic and the associated development of a vaccine shining a light on the sector, says a recent survey by Jefferies.
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.